Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 59935V107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RTW Investments, LP
13G/A
|
9.9% |
5/15/2026
Event 3/31/2026
|
||
| RTW Investments, LP | 9.9% | |||
| Roderick Wong | 9.9% | |||
|
Propel Bio Management, LLC
13G
|
9.9% |
12/23/2025
Event 7/11/2025
|
||
| Propel Bio Management, LLC | 9.9% | |||
| Leen Kawas | 9.9% | |||
| Richard Kayne | 9.9% | |||
| Propel Bio Partners LLC | 9.9% | |||
|
Pavaki Capital Management LLC
13G
|
7.3% |
8/7/2026
Event 12/31/2025
|
||
| Pavaki Capital Management LLC | 7.3% | |||
| Pavaki Capital Partners, LP | 7.3% | |||
| Ashok Rambhai Patel | 7.3% | |||
|
Adage Capital Management, L.P.
13G/A
|
6.4% |
5/13/2026
Event 3/31/2026
|
||
| Adage Capital Management, L.P. | 6.4% | |||
| Robert Atchinson | 6.4% | |||
| Phillip Gross | 6.4% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Trails Edge Capital Partners, LP
13G/A
|
4.3% |
3/26/2026
Event 3/20/2026
|
||
| Trails Edge Capital Partners, LP | 4.3% | |||
| Trails Edge Biotechnology Master Fund, LP | 4.3% | |||
| Ortav Yehudai | 4.3% | |||
|
Integrated Core Strategies (US) LLC
13G/A
|
0.6% |
4/30/2025
Event 3/31/2025
|
||
| Integrated Core Strategies (US) LLC | 0.6% | |||
| Millennium Management LLC | 0.6% | |||
| Millennium Group Management LLC | 0.6% | |||
| Israel A. Englander | 0.6% | |||
| BlackRock, Inc. 13G/A | 0% |
4/22/2025
Event 3/31/2025
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 1.29 M | $1.12 M |
| 2026 Q2 | 87 | 50.8 M | $68.1 M |
| 2026 Q1 | 91 | 39.5 M | $47.2 M |
| 2025 Q4 | 87 | 35.0 M | $70.7 M |
| 2025 Q3 | 66 | 34.1 M | $68.3 M |
| 2025 Q2 | 50 | 12.6 M | $24.4 M |
| 2025 Q1 | 49 | 11.8 M | $9.46 M |
| 2024 Q4 | 52 | 24.6 M | $57.9 M |
| 2024 Q3 | 45 | 28.7 M | $43.6 M |
| 2024 Q2 | 45 | 32.8 M | $43.3 M |
| 2024 Q1 | 48 | 33.0 M | $59.3 M |
| 2023 Q4 | 47 | 19.9 M | $33.2 M |
| 2023 Q3 | 41 | 19.5 M | $60.6 M |
| 2023 Q2 | 51 | 20.7 M | $59.0 M |
| 2023 Q1 | 54 | 21.7 M | $85.5 M |
| 2022 Q4 | 62 | 24.2 M | $97.0 M |
| 2022 Q3 | 65 | 22.5 M | $204 M |
| 2022 Q2 | 36 | 20.8 M | $127 M |
| 2022 Q1 | 31 | 21.0 M | $135 M |
| 2021 Q4 | 30 | 20.4 M | $134 M |
| 2021 Q3 | 32 | 20.0 M | $114 M |
| 2021 Q2 | 33 | 20.1 M | $111 M |
| 2021 Q1 | 41 | 20.3 M | $117 M |
| 2020 Q4 | 38 | 20.6 M | $138 M |
| 2020 Q3 | 33 | 15.5 M | $113 M |
| 2020 Q2 | 25 | 9.79 M | $37.0 M |
| 2020 Q1 | 19 | 9.24 M | $17.0 M |
| 2019 Q4 | 25 | 14.4 M | $231 M |
| 2019 Q3 | 24 | 13.1 M | $240 M |
| 2019 Q2 | 26 | 13.1 M | $350 M |